C4 Therapeutics Cash Flow Statement 2019-2025 | CCCC

Fifteen years of historical annual cash flow statements for C4 Therapeutics (CCCC).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202420232022202120202019
$-105.32$-132.49$-128.18$-83.89$-66.34$-34.10
$-3.58$-1.50$3.10$4.09$1.93$1.93
$36.09$34.09$35.91$22.93$10.33$2.80
$32.51$32.59$39.02$27.02$12.26$4.73
$8.70$-10.33$4.24$-1.23$0.14$81.82
$0$0$0$0$0$0
$-0.12$0.27$-3.33$-1.18$0.47$4.23
$0.34$1.80$-22.77$-32.06$-16.34$-4.78
$7.65$-6.94$-16.78$-30.09$-13.18$84.98
$-65.16$-106.84$-105.94$-86.97$-67.25$55.61
$-0.18$-1.71$-5.50$-1.28$-0.65$-1.29
$0$0$0$0$0$0
$0$0$0$0$0$0
$-51.09$160$-219.53$-188.06$-189.86$-0.33
$0$0$283$0$0$0
$-51.09$160$63.92$-188.06$-189.86$-0.33
$0$0$0$0$0$0
$-51.27$158$58.42$-189.34$-190.51$-1.62
$0$-12.50$0$0$11.97$0
$0$0$0$0$0$0
$0$-12.50$0$0$11.97$0
$44.95$57.62$0.78$172$195$0.24
$44.95$57.62$0.78$172$341$0.24
$0$0$0$0$0$0
$0.38$0.37$0.37$-0.40$-3.61$0
$45.34$45.49$1.15$171$349$0.24
$-71.09$97.00$-46.37$-104.90$91.18$54.24
$29.66$27.24$30.02$21.51$3.43$1.64
$0$0$0$0$0$0